Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

DM and AA may share a common cause.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Topical Imiquimod may fight vascular tumors by affecting blood vessels or the immune system, low iron might be linked to some hair loss, removing the top skin layer helps vitamin C get in, genetic testing helps diagnose skin conditions, and too much iron could worsen skin inflammation.

Researchers developed a new way to measure gene activity in single hair follicles and found that a specific gene's activity changes with different amounts and times of treatment.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Immune changes and specific genes contribute to male hair loss.

Higher levels of certain proteins in hair loss areas may help understand and treat hair loss.

The meeting presented new findings on hair stem cells, pigmentation, genetics, and modern hair treatment techniques.

A man with skin and hair symptoms improved partially with specific treatment.

Combination therapies might work better for some vitiligo patients, but results vary.

Fixing DNA errors is crucial to prevent skin cancer.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

A woman with chronic hepatitis C had a rare skin condition linked to her illness.

A woman's eyelashes grew thicker and longer after taking topiramate, but returned to normal when she stopped the medication.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Topical minoxidil showed promise for early male pattern baldness.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.